Interferon alfa-2a for melanoma metastases
- 1 March 2002
- journal article
- Published by Elsevier in The Lancet
- Vol. 359 (9310) , 978-979
- https://doi.org/10.1016/s0140-6736(02)08001-7
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Effect of long-term adjuvant therapy with interferon alpha-2a in patients with regional node metastases from cutaneous melanoma: a randomised trialThe Lancet, 2001
- High-Dose Interferon Alfa-2b Significantly Prolongs Relapse-Free and Overall Survival Compared With the GM2-KLH/QS-21 Vaccine in Patients With Resected Stage IIB-III Melanoma: Results of Intergroup Trial E1694/S9512/C509801Journal of Clinical Oncology, 2001
- Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.Journal of Clinical Oncology, 1996
- Results of adjuvant interferon study In WHO melanoma programmeThe Lancet, 1994